• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Expenditure of hospital care on cancer in China, from 2011 to 2015

    2017-09-06 09:04:58YueCaiMingXueWanqingChenMaoguiHuZhiwenMiaoLanLanRongshouZhengQunMeng
    Chinese Journal of Cancer Research 2017年3期

    Yue Cai, Ming Xue, Wanqing Chen, Maogui Hu, Zhiwen Miao, Lan Lan, Rongshou Zheng, Qun Meng

    1Center for Health Statistics and Information, National Health and Family Planning Commission, Beijing 100032, China;2National Central Cancer Registry, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;3State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China;4West China School of Public Health, Sichuan University, Chengdu 610041, China

    *These authors contributed equally to this work.

    Expenditure of hospital care on cancer in China, from 2011 to 2015

    Yue Cai1*, Ming Xue1*, Wanqing Chen2, Maogui Hu3, Zhiwen Miao1, Lan Lan4, Rongshou Zheng2, Qun Meng1

    1Center for Health Statistics and Information, National Health and Family Planning Commission, Beijing 100032, China;2National Central Cancer Registry, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;3State Key Laboratory of Resources and Environmental Information System, Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing 100101, China;4West China School of Public Health, Sichuan University, Chengdu 610041, China

    *These authors contributed equally to this work.

    Objective:A solid understanding of levels and trends of spending on cancer is important to evaluate whether our healthcare resources were wisely spent and to prioritize future resources for cancer treatment and prevention. However, studies on economic burden of cancers in China are scant and the results are inconsistent.

    Methods:The Chinese hospital information database and nearly 350 million inpatient medical record data were used. As the ratios of cancer inpatient payments to total inpatient payments were mainly influenced by the grades and sites of hospitals, the estimates of payments of cancer inpatients in this study were stratified by hospital grades and provinces. Only the payments of cancer inpatients happened in grade 2, grade 3 and specialized cancer hospitals were included in the analyses. The total medical payments of cancers in China were estimated based on the ratios of outpatient payments to inpatient payments in specialized cancer hospitals.

    Results:From 2011 to 2015, the payments of cancer inpatients in China have increased by 84.1% and the total inpatient payments reached 177.1 billion RMB in 2015, accounting for 4.3% of the total health expenditure in China. Based on the ratio of outpatient payments to inpatient payments, the total payments on cancer treatments in China were estimated to be 221.4 billion RMB in 2015. Among different cancer types, the highest payments were the treatment of trachea, bronchus and lung cancer. The major cancer inpatient payments (67.1% in 2015) spent in grade 3 general hospitals and this ratio increased continually from 2011 to 2015. The expenditure of cancer treatments also varies by region with the major expenditure in the eastern region of China.

    Conclusions:This study estimated the total payments of cancer treatments in China and analyzed how the money was spent on cancer treatments in the recent 5 years, which would provide information for decision makings on the allocation of resources to service provisioning, prevention strategies, research funding, and assessing whether the economic burden of cancer is affordable to the governments.

    Cancer; payments; expenditure; economic burden

    View this article at:https://doi.org/10.21147/j.issn.1000-9604.2017.03.11

    Introduction

    A solid understanding of levels and trends of spending on cancer is important to evaluate whether our healthcare resources were wisely spent and to prioritize future resources for cancer treatment and prevention. However,studies on economic burden of cancers in China are scant and the results are inconsistent (1,2). Most studies were carried out in specific regions or used data with poor representativeness. There were very few studies analyzed the expenditure of cancer patients changed over time and the distribution of payments over different types of cancers. Hu et al. used the National Health Service Survey and Vital Registration data to estimate the economic burden of noncommunicable chronic diseases in China in 2003 and showed that 25.6 billion RMB were spent on the inpatient and outpatient visits of cancers (1). However, the total expenditure of cancer care in China in the last decade is unknown. Considering the increasing incidence rate of cancer (3-5) and rising volume of outpatient and inpatient (6), it is urgently required to estimate the total payments for cancer treatment in China and provide scientific evidence for the policy formulation of health care and health insurance. This study used the national hospital information database (HID) and inpatient medical record home page (IMRHP) dataset to estimate the payments of cancer treatment in China, depicting a picture on how the money was spent on cancer treatments.

    Materials and methods

    Data source

    HID

    According to the Statistics Law of the People’s Republic of China and the Statistics Regulations of the National Health and Family Planning Commission (NHFPC), all the hospitals in China are required to report their basic information every year. As a non-profit affiliated institution of NHFPC, Center for Health Statistics and Information (CHSI) is responsible for collecting, analyzing and administrating the general statistics information including HID and IMRHPs. All these information are reported through the Health Statistics and Information Reporting System (HSRS) built by the CHSI. The HID mainly includes hospital’s properties, grades, staff numbers, number of beds, equipment condition, volume of outpatient and inpatient visits, incomes from outpatients and inpatients, and payments for medical service and human resource, etc. The data quality control was processed hierarchically. Every year before February, provincial CHSIs examine the data quality of hospital information and inform the hospitals of the results.

    Hospitals that fail to pass the examination need to report their basic information again in due time. Every year before March, the national CHSI examines the data quality and informs the provincial CHSIs of the results. Hospitals that fail to meet the quality requirements need to report the data once again. Except for that, data quality control meetings are held by the national CHSI every year and data quality supervision and inspection are carried out regularly. In this study, totally 5,215 hospitals in grade 3, 21,060 hospitals in grade 2 and 629 cancer specialized hospitals from 2011 to 2015 were included.

    IMRHPs

    The IMRHPs have been collected by the HSRS which is administered by the CHSI since 2008. The hospitals above grade 2 are required to report their IMRHP data quarterly. The main information of IMRHPs includes: patients’demographic information, code of diagnosis, code of surgery, results of treatments, types of health insurance, hospitalization expenses, etc. The validity and completeness of IMRHPs are controlled hierarchically. The data validity control mainly focuses on the logic check (i.e. male patients get female disease, infants get chronic disease). The completeness of IMRHPs is evaluated by two dimensions. One is about the completeness of item reporting for each IMRHP. The other dimension is about the completeness of the quantity of IMRHPs reporting. Provincial CHSIs check the quality of IMRHPs quarterly and give feedbacks to hospitals. The national CHSI examines the data quality yearly and gives feedback to provincial CHSIs. Besides, data quality control meetings, data quality supervision and inspections are carried out regularly. In this study, data of nearly 350 million inpatients were analyzed.

    Statistical analysis

    Icd-10 was used to code symptoms. Diseases were defined by the different ranges of icd-10 codes according to the Chinese hospital disease catalog (7). Considering that the ratios of cancer inpatient payments to total inpatient payments (RCITI) were mainly influenced by the grades and the sites of hospitals (8-10), the estimates of the payments of cancer inpatients were stratified by hospital grades and provinces. The inpatient incomes of hospitals by different grades and different provinces from 2011 to 2015 were summarized using the HID. The RCITIs ofhospitals by different grades and different provinces from 2011 to 2015 were estimated using the IMRHP database. The formula is as below:

    FEEcstands for the payments of inpatients for a specific type of cancer; Rcijstands for the RCITIs of specific cancer for hospitals of different grades and different provinces; and Feeijstands for the inpatient incomes for hospitals of different grades and different provinces.

    Since the IMRHP database from 2011 to 2015 only included the data from grade 2 and 3 hospitals (hospitals with more than 100 beds) and the duty of grade 1 hospitals is mainly about the provision of clinic treatment on very common diseases (such as influenza, and high blood pressure), disease prevention and patients referral services, this study only includes the payments in grade 2, grade 3 and specialized cancer hospitals.

    The ratio of outpatient payments to inpatient payments (ROI) of cancer was used to estimate the total expenditure of cancer care in China. Formerly, most analysts used simple rules-of-thumb, where the cost of outpatient is assumed to equal the cost of a specific number of inpatient, generally three or four (11-13). This approach is relatively straightforward as it requires only information on total or in- or out-patient hospital costs. However, the validity of applying the same ratio to all countries has been questioned by some scholars (14), who showed this ratio varied among countries. Instead of using the above approach, this study used the incomes from outpatients and inpatients of all specialized cancer hospitals in China to estimate the ROIs of cancer from 2011 to 2015.

    Results

    From 2011 to 2015, the payments for cancer inpatients in China have increased in both absolute values and inflation adjusted values. As to the absolute ones, the payments of total cancer inpatients have increased by 84.1%, which means the total expenses reached 177.1 billion RMB in 2015, accounting for 4.3% of the total health expenditure. As to the inflation adjusted ones (payment in constant 2011 RMB), the total cancer inpatient payments have increased by 69.1%, and the adjusted expenses reached 162.7 billion RMB in 2015. The growth rate in inpatient payments decelerated with 22.0% for 2011—2012 and 10.3% for 2014—2015.

    The inpatient payments of various cancers in some sites ranking top 9 of the 3rd national death retrospective survey (14) were estimated. The payment on trachea, bronchus and lung cancers was the highest, accounting for 11.0% of the total cancer inpatient payments in 2015, with an absolute value of 19.5 billion RMB. The total payments of all cancers have increased over the years. The highest rise was observed in the colon and rectum cancers with the absolute payment rising by 92.5% while the inflation adjusted payment by 76.8%. The lowest rise was the esophagus cancer with the absolute payment rising by 44.2% and the inflation adjusted payment by 32.4%. Significantly decelerated growth was observed in most of the diseases except for brain tumor, and the growth rate of payment has increased from 9.2% (2011—2012) to 11.0% (2014—2015) (Table 1).

    The payments of cancer inpatients have increased in all types of hospitals. From 2011 to 2015, the payments of grade 3 general hospitals have increased by 98.6% from 59.8 billion RMB to 118.8 billion RMB. The payments in cancer specialized hospitals have increased by 87.2% from 19.7 billion RMB to 36.8 billion RMB. The payment growth in grade 2 general hospitals has been slow but still with a 28.6% rise from 16.7 billion RMB to 21.5 billion RMB. The ratio of payments in grade 2 general hospitals to total payments of cancer inpatients decreased from 17.4% to 12.1%, while it increased from 62.2% to 67.1% in grade 3 general hospitals. The payments of cancer inpatients have been concentrated in grade 3 general hospitals over time.

    From 2011 to 2015, colon and rectum cancers had the highest increase rate, which was 33.9% in grade 2 general hospitals, 103.0% in grade 3 general hospitals and 117.0% in specialized cancer hospitals. Esophagus cancer had the lowest increase rate, which was 9.9% for grade 2 general hospitals, 42.8% for grade 3 general hospitals and 65.0% for specialized cancer hospitals. The major cancer inpatient payments happened in the grade 3 general hospitals, except for cervix uteri and corpus uteri cancer, for which, 46.0% of the payment happened in the specialized cancer hospitals in 2015, 45.9% in grade 3 general hospitals and only 8.1% in grade 2 general hospitals. For leukemia, 85.9% of the payment happened in grade 3 general hospitals, 10.6% in grade 2 general hospitals while only 3.4% in specialized cancer hospitals in 2015 (Table 2).

    From 2011 to 2015, around 58% cancer inpatient payments happened in the eastern region of China,reaching 104.0 billion RMB in 2015, while the payments in the middle region and west region were 46.2 billion and 26.9 billion RMB, respectively. From 2011 to 2015, the payments in the eastern region, the middle region and the western region have increased by 85.1%, 91.0% and 70.5%, respectively. However, the growth rate of payments has decelerated year by year. For example, the payments in the middle region increased by 28.0% from 2011 to 2012, while the growth rate fell to 8.8% from 2014 to 2015.

    Table 1 Hospitalization expenses of treatment for different cancers in China (100 million RMB)

    Similar trend has been found in different types of cancers, with major payments in the eastern region of China. The highest degree of concentration was observed in brain tumor. In 2015, 1.3 billion RMB were spent in the eastern region of China, accounting for 62.0% of the total payments of brain tumor. While only 0.5 billion RMB and 0.3 billion RMB were spent in the middle region and western region respectively. A relatively even distribution was observed in leukemia, with 1.6 billion RMB inpatient payments in the eastern region in 2015, 1.2 billion RMB in the middle region and 0.7 billion RMB in the westernregion. From 2011 to 2015, the highest growth rate of inpatient payments was observed in brain tumor in the eastern region (107.5%), colon and rectum cancer in the middle region (90.0%), and cervix uteri and corpus uteri cancer in the western region (86.7%) (Table 3).

    Table 2 Hospitalization expenses of cancer treatment in different types of hospitals (100 million RMB)

    The highest inpatient payments of cancer were observed in Jiangsu, reaching 17.0 billion RMB in 2015. The inpatient payments in Guangdong (16.8 billion), Zhejiang (11.6 billion) and Henan (10.9 billion) exceeded 10 billion as well. The above four provinces together have consumed 31.8% of the total cancer inpatient payments in China. Beijing and Shanghai spent tremendous money on cancer inpatients in contrast to their number of residents. In 2015, 9.4 billion and 8.6 billion RMB were spent in Beijing and Shanghai, respectively, much higher than the payments in Sichuan and Shanxi whose numbers of residents were much higher than Beijing and Shanghai (Figure 1).

    The health seeking behavior of cancer patients and accessibility of health care were measured by the ratios of cancer inpatient payments to the number of cancer deaths based on the GBD 2015 Study (15). The highest ratios were observed in Beijing, Shanghai and Tianjin, suggestingthat the inpatient payments were extremely high compared to the numbers of cancer deaths in these three cities. The lowest ratios were observed in Tibet, Sichuan and Guizhou, indicating that the inpatient payments of these three provinces were extremely low compared to the numbers of cancer deaths (Figure 2).

    Table 3 Hospitalization expenses of cancer treatment in different regions of China (100 million RMB)

    The ROIs were quite consistent from 2011 to 2015 (nearly 1:4). Based on the inpatient payments and ROIs, the total payments of cancer treatments, including inpatient treatment and outpatient treatment, were estimated. The total payments of cancer treatments in 2015 were 221.4 billion, which increased by 85.6% compared to that in 2011, accounting for 5.4% of the total health expenditure in China.

    Among all types of cancers, the highest payments presented in trachea, bronchus and lung cancers with 24.3 billion RMB in 2015, and the lowest was for brain tumor treatment with 2.5 billion in 2015. Compared to 2011, the payments for colon and rectum cancer treatment had the highest growth rate (94.0%), while the payments for esophagus cancer had the lowest growth rate (45.5%).

    Figure 1 Hospitalization expenses of cancer treatment (100 million RMB) in different provinces of China.

    For all types of cancers, the growth rate of treatment payments slowed down from 2011 to 2015, which decreased from 23.0% (2011—2012) to 11.2% (2014—2015). The highest decrease was observed in the breast cancer from 32.6% (2011—2012) to 11.5% (2014—2015) (Table 4).

    Discussion

    The total payments of cancer medical treatment (including in- and out-patient treatments) were 221.4 billion RMB in 2015, 8.6 times of those in 2003 (1). The growth rate was slightly higher than that of the total health expenditure, which was 6.2 times (from 658.4 billion RMB to 4,097.5 billion RMB) (14). With increasing medical insurance coverage, especially launching of the policy about the insurance of severe illness, the ratio of cancer payments to total payments and the growth rate of cancer payments compared to the total health expenditure were greatly increased in recent years. In European Union (EU), the costs of inpatient cancer care were estimated to be 28.4 billion Euro in 2009 (16), slightly higher than those in China in 2015 (28.4 billion Euro equals to 187.1 billion RMB). In the US, the total cost of cancer care (including the hospital care and self-care) was 124.6 billion USD in 2010 (17); using the proportion (40.0%) of hospital care cost over the total cost from the EU study (16), the hospital cost was estimated to be 49.8 billion USD, 34.6% higher than our estimates in 2015.

    The total expenditure of cancer medical treatment in 2015 (221.4 billion RMB) accounts for 5.4% of the total health expenditure, which is equal to 17.7% of the government health expenditure. Since 38% patients have not visited hospitals according to the 5th National Health Service Survey (18), the total expenditure would reach 357.1 billion RMB if these patients are induced. According to the requirements of the 13th Five-Year health care reform plan that the proportion of reimbursement of the basic medical insurance should be stable at 75%, the government would pay 250.0 billion RMB at most, which accounts for 20% of the government health expenditure.

    Figure 2 Ratios of cancer inpatient payments to cancer deaths in different provinces of China.

    Table 4 Health care expenses of cancer treatment in China (100 million RMB)

    The highest payment in trachea, bronchus and lung cancers and the fastest growth rate of payments in colon and rectum cancers hint the disease map of inpatient payments and the changing trends. The high proportion of cancer inpatient payments in grade 3 general hospitals and the low proportion in grade 2 general hospitals suggest that the health seeking behavior of cancer patients did not change over the past 5 years and will continue to concentrate to grade 3 general hospitals and specialized cancer hospitals.

    The expenditure of cancer treatments varies by regions with the major expenditure in the eastern region of China, and 12.4% of the total expenditure of cancer treatment happened in Beijing, Tianjin and Shanghai, which was equal to the expenditure of the 7 provinces of Gansu, Chongqing, Anhui, Shaanxi, Guizhou, Sichuan and Tibet.

    However, the number of death of cancer patients in Beijing, Tianjin and Shanghai is only about 12.7% of those in the above 7 provinces (15,19). The payments of cancer patients were mismatched with the numbers of cancer patients among provinces. This implies that cancer patients tend to visit doctors and have high rates of receiving medical treatment in developed areas. The provinces with higher ratios of cancer inpatient payments to number of cancer deaths imply the provinces gather more cancer patients seeking medical treatments.

    It should be noted that there are some limitations of this study. First, only the payments in grade 2, grade 3 general hospitals and specialized cancer hospitals were included in the analyses. Since the cancer payments in grade 1 or grassroots hospitals were not included, the estimates in the study could be lower than the actual cancer payments. Second, the ROIs generated from specialized cancer hospitals were used as the ROI of cancer patients in China. The ROI in specialized cancer hospitals may be different from the actual ROI of cancer patients, however, this is the best estimate we can make, and the consistent ROIs in specialized cancer hospitals from 2011 to 2015 suggested that this ratio could be quite steady in China.

    Conclusions

    This study estimates the total payments of cancer treatments in China in the recent 5 years, which would provide the information for decision makings on the allocation of resources to service provisioning, prevention strategies and research funding. It also provides reliable evidence to evaluate whether our government can afford the economic burden of cancer with increasing the medical insurance coverage.

    Acknowledgements

    This work was supported by National Natural Science Foundation of China (No.71403189).

    Footnote

    Conflicts of Interest: The authors have no conflicts of interest to declare.

    1.Hu J, Rao K, Qian J, et al. The Study of Economic Burden of Chronic Non-communicable Diseases in China. Zhongguo Man Xing Bing Yu Fang Yu Kong Zhi (in Chinese) 2007;15:189-93.

    2.Shi JF, Shi CL, Yue XP, et al. Economic burden of cancer in China during 1996-2014: a systematic review. Zhonghua Zhong Liu Za Zhi (in Chinese) 2016;38:929-41.

    3.Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011. Chin J Cancer Res 2015;27:2-12.

    4.Chen W, Zheng R, Zou T, et al. National cancer incidence and mortality in China, 2012. Chin J Cancer Res 2016;28:1-11.

    5.Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level. Chin J Cancer Res 2017;29:1-10.

    6.Cai Y, Wu R, Lan L, et al. The situation of disease distribution and resource consumption of Chinese inpatients during 2011-2015. Zhongguo Wei Sheng Tong Ji (in Chinese) 2017;34:298-300.

    7.National Health and Family Planning Commission. National Health and Family Planning Statistics Survey System, 2016. Beijing: Peking Union Medical College Press, 2016.

    8.Adam T, Evans DB. Determinants of variation in the cost of inpatient stays versus outpatient visits in hospitals: a multi-country analysis. Soc Sci Med 2006;63:1700-10.

    9.Lan L, Cai Y, Zhang T, et al. Influencing factors of inpatient expenditure pattern for cancer in China, 2015. Chin J Cancer Res 2017;29:11-7.

    10.Barnum H, Kutzin J. Public Hospitals in Developing Countries: Resource Use, Cost, Financing (World Bank). Baltimore: The Johns Hopkins University Press, 1993.

    11.Koné T, Silué A, Agness-Soumahoro J, et al. Expenditures on AIDS in C?te d’Ivoire. In: Ainsworth M, Fransen L, Over M, eds. Confronting AIDS: Evidence from the developing world. Brussels: European Commission, 1998:255-62.

    12.Mwikisa CN. HIV/AIDS Interventions in Zambia: financial Implications. The 10th General Assembly of CODESRIA, Kampala, Uganda. Dakar: CODESRIA, 2002:60. Available online: http://wwww.codesria. org/links/Home/Abstracts%20GA%201-5/ AIDs_Mwikisa2.htm

    13.Lombard CJ, Stegman JC, Barnard A. Modelling net expenditure of hospitals in the Cape Province. S Afr Med J 1991;80:508-10.

    14.National Health and Family Planning Commission. Statistical Yearbook of Health and Family Planning in China, 2016. Beijing: Peking Union Medical College Press, 2016.

    15.GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1459-544.

    16.Luengo-Fernandez R, Leal J, Gray A, et al. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 2013;14:1165-74.

    17.Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011;103:117-28.

    18.Center for Health Statistics and Information, NHFPC. An Analysis Report of National Health Services Survey in China, 2013. Beijing: Peking Union Medical College Press, 2016.

    19.Yang L, Yuan Y, Sun T, et al. Population-based cancer incidence analysis in Beijing, 2008-2012. Chin J Cancer Res 2015;27:13-21.

    Cite this article as:Cai Y, Xue M, Chen W, Hu M, Miao Z, Lan L, Zheng R, Meng Q. Expenditure of hospital care on cancer in China, from 2011 to 2015. Chin J Cancer Res 2017;29(3):253-262. doi: 10.21147/j.issn.1000-9604. 2017.03.11

    Qun Meng. Center for Health Statistics and Information, National Health and Family Planning Commission, Beijing 100032, China. Email: mengqun@nhfpc.gov.cn.

    10.21147/j.issn.1000-9604.2017.03.11

    Submitted May 10, 2017. Accepted for publication Jun 08, 2017.

    欧美一级a爱片免费观看看 | www日本黄色视频网| 亚洲男人的天堂狠狠| 香蕉国产在线看| 我要搜黄色片| 亚洲国产欧美人成| 亚洲精品美女久久久久99蜜臀| 国产精品久久久av美女十八| 村上凉子中文字幕在线| 一进一出抽搐gif免费好疼| 婷婷亚洲欧美| 熟妇人妻久久中文字幕3abv| 夜夜躁狠狠躁天天躁| 中文在线观看免费www的网站 | 国产精品国产高清国产av| 精品高清国产在线一区| 国产激情久久老熟女| 久久这里只有精品19| 禁无遮挡网站| 亚洲精品久久国产高清桃花| 欧美日韩亚洲综合一区二区三区_| 国产一区二区在线av高清观看| 一进一出好大好爽视频| 村上凉子中文字幕在线| 又粗又爽又猛毛片免费看| 精品国产亚洲在线| 亚洲精品在线美女| 一区二区三区激情视频| 日韩国内少妇激情av| 欧美乱码精品一区二区三区| 好看av亚洲va欧美ⅴa在| 99久久99久久久精品蜜桃| 国产精品野战在线观看| 99精品在免费线老司机午夜| 国产精品永久免费网站| 久久久久国产一级毛片高清牌| 99热6这里只有精品| 久久中文字幕人妻熟女| 99精品欧美一区二区三区四区| 日韩精品免费视频一区二区三区| 人人妻人人澡欧美一区二区| 亚洲国产高清在线一区二区三| 黄色成人免费大全| 欧美日本视频| 免费在线观看日本一区| 国产片内射在线| 精品久久久久久成人av| 免费在线观看成人毛片| 三级毛片av免费| 可以在线观看的亚洲视频| tocl精华| 国产真实乱freesex| av福利片在线| 欧美色视频一区免费| 国产熟女午夜一区二区三区| 最近在线观看免费完整版| 成人手机av| 一本久久中文字幕| 制服诱惑二区| 18禁黄网站禁片午夜丰满| xxxwww97欧美| 国产69精品久久久久777片 | 18美女黄网站色大片免费观看| 国模一区二区三区四区视频 | 日韩欧美免费精品| www.999成人在线观看| 丰满人妻一区二区三区视频av | 亚洲国产欧美人成| 欧美性猛交黑人性爽| 成在线人永久免费视频| 国产一区二区在线av高清观看| 长腿黑丝高跟| 日韩三级视频一区二区三区| 国产欧美日韩一区二区三| 亚洲熟妇中文字幕五十中出| 日韩三级视频一区二区三区| 久久久久久久午夜电影| 麻豆国产97在线/欧美 | 久久九九热精品免费| 亚洲欧美日韩高清专用| 午夜精品久久久久久毛片777| 久久性视频一级片| 麻豆成人午夜福利视频| 黄色片一级片一级黄色片| 亚洲欧美激情综合另类| 午夜福利成人在线免费观看| 欧美国产日韩亚洲一区| 九色国产91popny在线| 91老司机精品| 午夜精品一区二区三区免费看| 夜夜躁狠狠躁天天躁| 丁香六月欧美| 99精品在免费线老司机午夜| 国产成人av激情在线播放| 91老司机精品| 天堂av国产一区二区熟女人妻 | 少妇粗大呻吟视频| av天堂在线播放| 国产av一区二区精品久久| 无遮挡黄片免费观看| 精品久久久久久久人妻蜜臀av| 蜜桃久久精品国产亚洲av| 国产人伦9x9x在线观看| 毛片女人毛片| 欧美人与性动交α欧美精品济南到| 精品久久久久久久久久久久久| 看片在线看免费视频| av福利片在线观看| 色在线成人网| 女生性感内裤真人,穿戴方法视频| 亚洲熟妇熟女久久| 国产精品香港三级国产av潘金莲| 欧美一级毛片孕妇| 国产69精品久久久久777片 | 久久中文字幕人妻熟女| 免费看美女性在线毛片视频| 男女视频在线观看网站免费 | 国内精品一区二区在线观看| 亚洲一区二区三区不卡视频| 日韩精品中文字幕看吧| 日本成人三级电影网站| 97碰自拍视频| 国产精品久久久人人做人人爽| 亚洲男人天堂网一区| 久久久久久大精品| 一级片免费观看大全| 热99re8久久精品国产| 欧美一级毛片孕妇| 久久久久久久久中文| 色综合婷婷激情| 国产免费男女视频| av免费在线观看网站| 大型黄色视频在线免费观看| 美女大奶头视频| 在线免费观看的www视频| 国产精品爽爽va在线观看网站| 色播亚洲综合网| 日本一二三区视频观看| av片东京热男人的天堂| 国产aⅴ精品一区二区三区波| 看黄色毛片网站| 777久久人妻少妇嫩草av网站| 亚洲人成网站在线播放欧美日韩| 国产精品久久久久久亚洲av鲁大| 搡老岳熟女国产| 午夜福利欧美成人| 欧美黑人欧美精品刺激| 91成年电影在线观看| 亚洲精华国产精华精| 非洲黑人性xxxx精品又粗又长| 老司机福利观看| 精品一区二区三区av网在线观看| 成人国产综合亚洲| 成人特级黄色片久久久久久久| 国产av在哪里看| 婷婷六月久久综合丁香| 丝袜美腿诱惑在线| 青草久久国产| 欧美成人免费av一区二区三区| 制服人妻中文乱码| 国产午夜精品论理片| 女同久久另类99精品国产91| 少妇人妻一区二区三区视频| 亚洲av成人av| 亚洲性夜色夜夜综合| 搡老妇女老女人老熟妇| 欧美成狂野欧美在线观看| 可以免费在线观看a视频的电影网站| 国产av一区在线观看免费| 精品一区二区三区av网在线观看| 中文资源天堂在线| 老熟妇乱子伦视频在线观看| 欧美另类亚洲清纯唯美| 日日爽夜夜爽网站| 亚洲精品一卡2卡三卡4卡5卡| 嫩草影视91久久| 免费av毛片视频| 国产一区二区三区在线臀色熟女| 最近最新免费中文字幕在线| 毛片女人毛片| 午夜福利成人在线免费观看| 可以在线观看毛片的网站| 亚洲欧美精品综合一区二区三区| 成人av一区二区三区在线看| 中文字幕人成人乱码亚洲影| 亚洲熟妇熟女久久| 欧美黑人巨大hd| 在线观看免费午夜福利视频| 国产成人啪精品午夜网站| 人人妻人人看人人澡| 国产午夜福利久久久久久| 啦啦啦免费观看视频1| 国产三级黄色录像| av超薄肉色丝袜交足视频| 精品一区二区三区四区五区乱码| 欧美中文日本在线观看视频| 国产又黄又爽又无遮挡在线| 一本大道久久a久久精品| 亚洲 国产 在线| 国产精品一区二区三区四区久久| 夜夜爽天天搞| 老司机午夜十八禁免费视频| 久久人妻av系列| 久久精品亚洲精品国产色婷小说| 三级国产精品欧美在线观看 | 亚洲全国av大片| 国产蜜桃级精品一区二区三区| av在线天堂中文字幕| 在线观看日韩欧美| 久久热在线av| 欧美日韩国产亚洲二区| 亚洲一区二区三区色噜噜| 国产在线观看jvid| 九九热线精品视视频播放| 两性夫妻黄色片| 午夜成年电影在线免费观看| 中文资源天堂在线| 久久精品人妻少妇| 宅男免费午夜| cao死你这个sao货| 久久精品国产99精品国产亚洲性色| 久久午夜综合久久蜜桃| 成人高潮视频无遮挡免费网站| 国产男靠女视频免费网站| 国产精品日韩av在线免费观看| 麻豆国产av国片精品| 国产高清videossex| 亚洲国产精品合色在线| 99国产极品粉嫩在线观看| 久久精品影院6| 一边摸一边抽搐一进一小说| 婷婷丁香在线五月| 精品久久久久久久人妻蜜臀av| 日韩中文字幕欧美一区二区| 国产蜜桃级精品一区二区三区| 国产成人精品久久二区二区91| 桃色一区二区三区在线观看| 成人欧美大片| 动漫黄色视频在线观看| 精品乱码久久久久久99久播| 国产精品久久视频播放| 免费看日本二区| 亚洲中文日韩欧美视频| 少妇粗大呻吟视频| 丰满人妻一区二区三区视频av | 嫁个100分男人电影在线观看| 精品无人区乱码1区二区| 中文在线观看免费www的网站 | 国产伦人伦偷精品视频| 国产成人一区二区三区免费视频网站| 欧美最黄视频在线播放免费| 黑人巨大精品欧美一区二区mp4| 亚洲国产看品久久| 叶爱在线成人免费视频播放| 三级毛片av免费| 人妻丰满熟妇av一区二区三区| 国产视频一区二区在线看| 久久天堂一区二区三区四区| 欧美成人性av电影在线观看| 久久久久性生活片| 日日夜夜操网爽| 国产一区二区三区视频了| 美女黄网站色视频| 日本 欧美在线| 欧美成人免费av一区二区三区| 亚洲自偷自拍图片 自拍| 亚洲美女黄片视频| 极品教师在线免费播放| 99热6这里只有精品| 成人欧美大片| 麻豆久久精品国产亚洲av| 免费电影在线观看免费观看| 又大又爽又粗| 久久久久精品国产欧美久久久| 精品福利观看| av在线播放免费不卡| 黄色视频,在线免费观看| 亚洲成人久久爱视频| 中文字幕久久专区| 全区人妻精品视频| 久久天堂一区二区三区四区| 99riav亚洲国产免费| 91大片在线观看| 小说图片视频综合网站| 1024香蕉在线观看| 色精品久久人妻99蜜桃| 最新在线观看一区二区三区| 搞女人的毛片| 日本五十路高清| 一本久久中文字幕| 欧美丝袜亚洲另类 | 国产免费av片在线观看野外av| 男女视频在线观看网站免费 | 精华霜和精华液先用哪个| 色在线成人网| 黑人巨大精品欧美一区二区mp4| 亚洲国产精品久久男人天堂| 国产伦人伦偷精品视频| www.自偷自拍.com| 黄色a级毛片大全视频| 久久香蕉激情| 久久久久久亚洲精品国产蜜桃av| 成人精品一区二区免费| 亚洲精品在线美女| 国产精品九九99| 国内精品久久久久久久电影| 一本大道久久a久久精品| 日韩 欧美 亚洲 中文字幕| 色精品久久人妻99蜜桃| 观看免费一级毛片| 精品少妇一区二区三区视频日本电影| 日本精品一区二区三区蜜桃| 一级作爱视频免费观看| 国产av麻豆久久久久久久| 最好的美女福利视频网| 一个人免费在线观看电影 | 国产精品 欧美亚洲| 小说图片视频综合网站| 丰满人妻一区二区三区视频av | 国产精品一区二区精品视频观看| 亚洲国产精品sss在线观看| 色精品久久人妻99蜜桃| 日日爽夜夜爽网站| 神马国产精品三级电影在线观看 | 中文字幕av在线有码专区| 午夜福利18| 日韩av在线大香蕉| 九色国产91popny在线| 一进一出抽搐gif免费好疼| 久久久久久久午夜电影| 欧美色欧美亚洲另类二区| 又黄又粗又硬又大视频| 午夜a级毛片| 日本一二三区视频观看| 日日爽夜夜爽网站| av国产免费在线观看| 日本一二三区视频观看| 欧美高清成人免费视频www| 国产主播在线观看一区二区| 青草久久国产| 中文资源天堂在线| 久久这里只有精品中国| 麻豆成人午夜福利视频| 熟妇人妻久久中文字幕3abv| 久久这里只有精品中国| 国产av又大| 搞女人的毛片| 国产精品一及| 无人区码免费观看不卡| xxx96com| 欧美又色又爽又黄视频| 欧美黑人巨大hd| 亚洲av中文字字幕乱码综合| 亚洲国产精品999在线| 俺也久久电影网| 亚洲一区二区三区不卡视频| 一进一出好大好爽视频| 欧美日韩福利视频一区二区| 黄色a级毛片大全视频| 亚洲欧美日韩无卡精品| 99riav亚洲国产免费| netflix在线观看网站| 日本 av在线| 一本一本综合久久| 欧美乱色亚洲激情| 国产精品久久久av美女十八| 亚洲av熟女| 日本三级黄在线观看| 亚洲中文字幕一区二区三区有码在线看 | 久久久久国产一级毛片高清牌| 亚洲欧美精品综合一区二区三区| 久久久水蜜桃国产精品网| 两人在一起打扑克的视频| 白带黄色成豆腐渣| 免费在线观看完整版高清| 久久久久性生活片| 曰老女人黄片| 长腿黑丝高跟| 欧美色欧美亚洲另类二区| av福利片在线观看| 黄色视频不卡| 色av中文字幕| 国产一级毛片七仙女欲春2| 在线观看美女被高潮喷水网站 | 一夜夜www| 亚洲avbb在线观看| 一区二区三区高清视频在线| 我要搜黄色片| 天堂影院成人在线观看| 波多野结衣高清无吗| 免费看十八禁软件| 天堂av国产一区二区熟女人妻 | 人成视频在线观看免费观看| 黑人欧美特级aaaaaa片| 国产精品影院久久| 免费人成视频x8x8入口观看| 怎么达到女性高潮| 丁香欧美五月| 真人一进一出gif抽搐免费| 久久久久免费精品人妻一区二区| 少妇被粗大的猛进出69影院| 午夜激情福利司机影院| 欧美激情久久久久久爽电影| 中文字幕人妻丝袜一区二区| 夜夜夜夜夜久久久久| 国语自产精品视频在线第100页| 国产一区二区激情短视频| 欧美一级毛片孕妇| 悠悠久久av| 啪啪无遮挡十八禁网站| 欧美最黄视频在线播放免费| 日韩 欧美 亚洲 中文字幕| 欧美日韩一级在线毛片| 777久久人妻少妇嫩草av网站| 亚洲国产精品sss在线观看| 国产成人精品久久二区二区91| 免费在线观看日本一区| 亚洲成人中文字幕在线播放| 久久香蕉激情| 麻豆成人av在线观看| 99国产综合亚洲精品| 99热这里只有是精品50| 亚洲国产精品sss在线观看| 两性夫妻黄色片| 国产伦一二天堂av在线观看| 久久这里只有精品中国| 精品无人区乱码1区二区| 国产精品99久久99久久久不卡| 九九热线精品视视频播放| 国产av一区在线观看免费| av天堂在线播放| 又大又爽又粗| 成人永久免费在线观看视频| 天堂动漫精品| 亚洲avbb在线观看| 18禁观看日本| 亚洲九九香蕉| 成人一区二区视频在线观看| av国产免费在线观看| 午夜精品久久久久久毛片777| 手机成人av网站| 露出奶头的视频| 日本一本二区三区精品| 国产男靠女视频免费网站| 国产亚洲av嫩草精品影院| 亚洲欧美日韩东京热| 亚洲18禁久久av| 亚洲国产中文字幕在线视频| 男人舔女人的私密视频| 亚洲av熟女| 国产成人精品久久二区二区免费| 久久天躁狠狠躁夜夜2o2o| а√天堂www在线а√下载| xxx96com| 欧美av亚洲av综合av国产av| 真人一进一出gif抽搐免费| 国产乱人伦免费视频| 一进一出好大好爽视频| 99精品久久久久人妻精品| 久热爱精品视频在线9| 最近视频中文字幕2019在线8| 国产在线精品亚洲第一网站| 国产主播在线观看一区二区| 国产成人欧美在线观看| 午夜两性在线视频| 日日干狠狠操夜夜爽| 女人爽到高潮嗷嗷叫在线视频| 日韩欧美三级三区| 欧洲精品卡2卡3卡4卡5卡区| 精品人妻1区二区| 99精品久久久久人妻精品| 女同久久另类99精品国产91| 欧美在线一区亚洲| 一本大道久久a久久精品| videosex国产| 久久午夜综合久久蜜桃| 美女午夜性视频免费| 国产69精品久久久久777片 | 日韩欧美 国产精品| 日韩高清综合在线| 婷婷亚洲欧美| 黄频高清免费视频| 搡老熟女国产l中国老女人| 天堂动漫精品| 欧美极品一区二区三区四区| 亚洲 国产 在线| 香蕉国产在线看| 一级黄色大片毛片| 99国产精品一区二区蜜桃av| 一本综合久久免费| 国产黄a三级三级三级人| 久久午夜综合久久蜜桃| 国产高清激情床上av| 国产成人欧美在线观看| 日本免费一区二区三区高清不卡| 成年人黄色毛片网站| 亚洲专区国产一区二区| 99国产综合亚洲精品| 99精品在免费线老司机午夜| 久久亚洲精品不卡| 亚洲一区高清亚洲精品| 亚洲专区中文字幕在线| www.www免费av| 国产精品99久久99久久久不卡| 性色av乱码一区二区三区2| 亚洲中文日韩欧美视频| 波多野结衣高清作品| 国产又黄又爽又无遮挡在线| 欧美黑人精品巨大| 国产精品亚洲av一区麻豆| 好男人电影高清在线观看| 欧美日韩一级在线毛片| 两个人的视频大全免费| 欧美乱妇无乱码| 妹子高潮喷水视频| 日韩大码丰满熟妇| 又黄又爽又免费观看的视频| 听说在线观看完整版免费高清| 窝窝影院91人妻| 日本精品一区二区三区蜜桃| 九色国产91popny在线| 午夜免费观看网址| 国产成人啪精品午夜网站| 国产一区在线观看成人免费| 成人国语在线视频| 免费看a级黄色片| 亚洲成a人片在线一区二区| 免费看a级黄色片| 精品一区二区三区四区五区乱码| 国产高清视频在线播放一区| 最近在线观看免费完整版| 身体一侧抽搐| 后天国语完整版免费观看| 动漫黄色视频在线观看| 久久亚洲真实| 老司机在亚洲福利影院| 国产精品久久久久久人妻精品电影| 又黄又粗又硬又大视频| 国产伦人伦偷精品视频| 日韩国内少妇激情av| 男女之事视频高清在线观看| 亚洲专区字幕在线| 我要搜黄色片| 岛国在线观看网站| 国产精品 国内视频| 亚洲精品一卡2卡三卡4卡5卡| 亚洲精品久久国产高清桃花| 国产精品亚洲一级av第二区| 国产精品 国内视频| 在线a可以看的网站| 嫁个100分男人电影在线观看| 亚洲中文字幕一区二区三区有码在线看 | 国产免费av片在线观看野外av| www.熟女人妻精品国产| 亚洲美女视频黄频| 伦理电影免费视频| 中文字幕人妻丝袜一区二区| 99精品在免费线老司机午夜| 久久久久久国产a免费观看| 色综合婷婷激情| 叶爱在线成人免费视频播放| 久久精品亚洲精品国产色婷小说| 久久人妻福利社区极品人妻图片| 国产成+人综合+亚洲专区| 久久中文字幕一级| 不卡av一区二区三区| 51午夜福利影视在线观看| 天天一区二区日本电影三级| 亚洲黑人精品在线| 午夜影院日韩av| 欧美成人免费av一区二区三区| 国产一区二区在线观看日韩 | 男人舔奶头视频| 国产97色在线日韩免费| 欧美在线黄色| 国产av一区在线观看免费| 一a级毛片在线观看| 欧美成人免费av一区二区三区| 日韩免费av在线播放| 这个男人来自地球电影免费观看| 国产精品98久久久久久宅男小说| 日本 欧美在线| 免费无遮挡裸体视频| 久久久久九九精品影院| 亚洲精品在线美女| 人成视频在线观看免费观看| 99久久99久久久精品蜜桃| 制服丝袜大香蕉在线| 欧美精品啪啪一区二区三区| 国产成年人精品一区二区| 蜜桃久久精品国产亚洲av| 国产精品,欧美在线| 日日夜夜操网爽| 久久久国产精品麻豆| 两性午夜刺激爽爽歪歪视频在线观看 | 一级作爱视频免费观看| 神马国产精品三级电影在线观看 | 免费看a级黄色片| 亚洲第一欧美日韩一区二区三区| 亚洲片人在线观看| 精品第一国产精品| 国产三级黄色录像| 香蕉久久夜色| 日本 欧美在线| 999久久久精品免费观看国产| 日韩有码中文字幕| 久久国产乱子伦精品免费另类| 日韩欧美在线二视频| 亚洲精品色激情综合| 真人做人爱边吃奶动态| 51午夜福利影视在线观看| 一二三四在线观看免费中文在| 1024视频免费在线观看| 亚洲国产高清在线一区二区三| 18禁黄网站禁片午夜丰满|